Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Monday's After-Market Session

Author: Benzinga Insights | February 26, 2024 05:31pm

Gainers

  • Janux Therapeutics (NASDAQ:JANX) shares moved upwards by 64.2% to $24.8 during Monday's after-market session. The company's market cap stands at $1.1 billion.
  • ICU Medical (NASDAQ:ICUI) stock increased by 59.8% to $168.75. The market value of their outstanding shares is at $4.0 billion.
  • Galera Therapeutics (NASDAQ:GRTX) stock increased by 27.6% to $0.24. The market value of their outstanding shares is at $13.3 million.
  • Hims & Hers Health (NYSE:HIMS) shares increased by 15.9% to $11.88. The company's market cap stands at $2.5 billion. The company's, Q4 earnings came out today.
  • TransMedics Gr (NASDAQ:TMDX) shares increased by 15.84% to $90.06. The company's market cap stands at $2.9 billion. As per the news, the Q4 earnings report came out today.
  • BiomX (AMEX:PHGE) shares rose 13.89% to $0.24. The market value of their outstanding shares is at $11.0 million.

Losers

  • NRX Pharmaceuticals (NASDAQ:NRXP) stock decreased by 20.5% to $0.34 during Monday's after-market session. The market value of their outstanding shares is at $28.9 million.
  • Enliven Therapeutics (NASDAQ:ELVN) shares decreased by 8.89% to $16.0. The company's market cap stands at $659.3 million.
  • BioSig Technologies (NASDAQ:BSGM) stock declined by 7.08% to $0.45. The company's market cap stands at $4.1 million.
  • ThermoGenesis Holdings (NASDAQ:THMO) shares fell 7.06% to $0.79. The market value of their outstanding shares is at $2.4 million.
  • Assure Hldgs (NASDAQ:IONM) shares declined by 5.01% to $0.35. The company's market cap stands at $2.3 million.
  • Kazia Therapeutics (NASDAQ:KZIA) shares decreased by 4.99% to $0.28. The company's market cap stands at $7.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BSGM ELVN GRTX HIMS ICUI IONM JANX KZIA NRXP PHGE THMO TMDX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist